Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens

Journal of Steroid Biochemistry and Molecular Biology

Volumn 99, Issue 2-3, 2006, Pages 108-114

  García Becerra, Rocio ^a   Borja Cacho, Elizabeth ^a   Cooney, Austin J ^b   Smith, Carolyn L ^b   Lemus, Ana E ^c   Pérez Palacios, Gregorio ^d   Larrea, Fernando ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c DEPARTAMENTO DE QUÍMICA   (Mexico)

^d INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Coactivators; Estrogen action; Estrogen receptors; Progestins; Selective ligands

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NANDROLONE DERIVATIVE; STEROID RECEPTOR COACTIVATOR 1; TRYPSIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING;

ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; HELA CELLS; HISTONE ACETYLTRANSFERASES; HUMANS; MIFEPRISTONE; NANDROLONE; PROGESTERONE; PROGESTINS; PROTEIN CONFORMATION; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; TRYPSIN;

EID: 33646178258     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.01.005     Document Type: Article

References (28)

1. Katzenellenbogen J.A., and Katzenellenbogen B.S. Nuclear hormone receptors: ligand activated regulators of transcription and diverse cell responses. Chem. Biol. 3 (1966) 529-536
2. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
3. Tsai M.J., and O'Malley B.M. Molecular mechanism of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486
4. Beekman L.M., Allan G.F., Tsai S.Y., Tsai M.-J., and O'Malley B.M. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7 (1993) 1266-1274
5. Larrea F., Vilchis F., Chávez B., Pérez B.A.E., Garza-Flores J., and Pérez-Palacios G. The metabolism of 19-nor contraceptive progestins modulates their biological activity at the neuroendocrine level. J. Steroid Biochem. 27 (1987) 657-663
6. Vilchis F., Chávez B., Pérez A.E., García G.A., Angeles A., and Pérez-Palacios G. Evidence that a non-aromatizable metabolite of norethisterone induces estrogen-dependent pituitary progestin receptors. J. Steroid Biochem. 24 (1986) 525-531
7. Larrea F., García-Becerra R., Lemus A.E., García G.A., Pérez-Palacios G., Jackson K.J., Coleman K.M., Dace R., Smith C.L., and Cooney A.J. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonist for ERα. Endocrinology 142 (2001) 3791-3799
8. García-Becerra R., Borja-Cacho E., Cooney A.J., Jackson K.J., Lemus A.E., Pérez-Palacios G., and Larrea F. The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-α. J. Steroid Biochem. Mol. Biol. 82 (2002) 333-341
9. Lemus A.E., Zaga V., Santillán R., García G.A., Grillasca I., Damián-Matsumura P., Jackson K.J., Cooney A.J., Larrea F., and Pérez-Palacios G. The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites. J. Endocrinol. 165 (2000) 693-702
10. Nawaz Z., Lonard D.M., Smith C.L., Tsai S.Y., Tsai M.-J., and O'Malley B.W. The Angelman syndrome-associated gene E6-AP is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell Biol. 19 (1999) 1182-1189
11. Nawaz Z., Lonard D.M., Dennis A.P., Smith C.L., and O'Malley B.M. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1858-1862
12. Coleman K.M., Dutertre M., El-Gharbawy A., Rowan B.G., Weigel N.L., and Smith C.L. Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s). J. Biol. Chem. 278 (2003) 12834-12845
13. Dutertre M., and Smith C.L. Ligand-independent interactions of p160/SRC coactivators and CREB binding protein with estrogen receptor-α: regulation of phosphorylation sites in the A/B region depends on other receptor domains. Mol. Endocrinol. 17 (2003) 1296-1314
14. Jaber B.M., Mukopadhyay R., and Smith C.L. Estrogen receptor-α interaction with CREB binding protein coactivator is regulated by the cellular environment. J. Mol. Endocrinol. 32 (2004) 307-323
15. Zeng Z., Allan G.F., Thaller C., Cooney A.J., Tsai S.Y., O'Malley B.M., and Tsai M.-J. Detection of potential ligands for nuclear receptors in cellular extracts. Endocrinology 135 (1994) 248-252
16. García-Becerra R., Cooney A.J., Borja-Cacho E., Lemus A.E., Pérez-Palacios G., and Larrea F. Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins. J. Steroid Biochem. Mol. Biol. 91 (2004) 21-27
17. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
18. Allan G.F., Leng X., Tsai S.Y., Weigel N.L., Edwards D.P., Tsai M.-J., and O'Malley B. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267 (1992) 19513-19520
19. Kraichely D.M., Sun J., Katzenellenbogen J.S., and Katzenellenbogen B.S. Conformational changes and coactivator recruitment by novel ligands to estrogen receptor-α and estrogen receptor-β: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 141 (2000) 3534-3545
20. Lazennec G., Ediger T.R., Petz L.N., Nardulli A.M., and Katzenellenbogen B.S. Mechanistic aspects of the estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and corregulator interactions and receptor conformational changes. Mol. Endocrinol. 11 (1997) 1375-1386
21. Chávez B.A., Vilchis F., Pérez A.E., García G.A., Grillasca I., and Pérez-Palacios G. Stereospecificity of the intracellular binding of norethisterone and its A-ring reduced metabolites. J. Steroid Biochem. Mol. Biol. 22 (1985) 121-126
22. Bramlett K.S., Wu Y., and Burris T.P. Ligands specificity coactivator nuclear receptor (NR) bos affinity for estrogen receptor subtypes. Mol. Endocrinol. 15 (2001) 909-922
23. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.-A., and Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
24. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., and Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 (1998) 927-937
25. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of the estrogen receptors α and β. Endocrinology 138 (1997) 863-870
26. Delaunay F., Pettersson K., Tujague M., and Gustafsson J.-A. Functional differences between the amino-terminal domains of estrogen receptors α and β. Mol. Pharmacol. 58 (2000) 584-590
27. 3H-labeled androgens to the estrogen receptor. Endocrinology 104 (1979) 1797-1804
28. Thieulant M.L., Samperez S., and Jouan P. Evidence for 5α-androstane-3β-diol binding to the estrogen receptor in the cytosol from male rat pituitary. Endocrinology 108 (1981) 1552-1560